Home » Topics » BioWorld Science

BioWorld Science
RSS

Catalent patents decorin-containing products for cancer

Jan. 22, 2020

Multitrait analysis predicts glaucoma susceptibility, progression

Jan. 22, 2020

TWIST1 as a new risk gene for coronary artery disease and stroke

Jan. 22, 2020

rVSVN4CT1-EBOVGP1 Ebola virus vaccine demonstrates safety and immunogenicity in phase I study

Jan. 22, 2020

Results from GLP preclinical study of AAV8-hCocH gene therapy

Jan. 22, 2020

TMPRSS11B as a new therapeutic target in NSCLC

Jan. 22, 2020

FDA clears IND application for KAN-101 for the treatment of celiac disease

Jan. 22, 2020

Initiation of first-in-human study of SBT-272

Jan. 22, 2020

Young blood not all it's cracked up to be

Jan. 22, 2020

African Americans' lung tumors have unstable genomes

Jan. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...